Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lurasidone in children and adolescents with bipolar I depression
2013-004903-37Phase 3Withdrawn
- Sponsor
- Sunovion
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bipolar I disorder and bipolar disorder (BD) comparing Lurasidone with Placebo (2 arms). Primary endpoint: Change from baseline to Week 6 in Children's Depression Rating Scale, Revised total score. Planned start Apr 2014; status: withdrawn.
02
Drugs
lurasidone
03
Conditions
bipolar I disorderbipolar disorder (BD)
Beyond the preview
Go deeper on 2013-004903-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004903-37.